Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Theravance Biopharma
Financials
Theravance, Ultragenyx sell royalties for $1.8B
Theravance sold Trelegy royalties to Royalty Pharma for $1.31 billion, while Ultragenyx sold 30% of royalties on Crysvita to OMERS for $500 million.
Zoey Becker
Jul 14, 2022 11:48am
Viatris and Theravance emphasize one-a-day Yupelri for COPD
Jan 19, 2021 8:30am